SEC Filing Details

SEC Filing Details

Document Details

Form
Filing Date
Feb 4, 2022
Document Date
Feb 2, 2022
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
CytomX Therapeutics, Inc.
Issuer
CytomX Therapeutics, Inc.
Filer
ROWLAND LLOYD A